根据各州的美国痴呆症护理支出:2010-2019年
Amy Lastuka1, Michael R Breshock1, Theresa A McHugh1
1Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|February 27, 2024
概括
2019年,美国痴呆症护理的间接成本相当大,失去了580亿美元的工资,如果被卫生助理取代,则损失了2300亿美元. 预计到2050年,这些痴呆症护理成本将近翻一番.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
背景情况:
- 痴呆症是美国老年人的首要死亡原因,造成了巨大的经济成本.
- 目前对痴呆症间接成本的估计已经过时,缺乏国家层面的细节.
- 了解痴呆症护理的经济负担对于政策和资源配置至关重要.
研究的目的:
- 估计和预测美国州级非正式痴呆症护理的间接成本.
- 为2010年至2050年提供最新的成本数据.
- 分析痴呆症护理费用在各州的变化.
主要方法:
- 利用来自多项调查的数据来计算成本估计.
- 开发了2050年非正式痴呆症护理费用的预测.
- 分析了按常见情况和各州的成本.
主要成果:
- 2019年,非正式痴呆症护理的年度替代成本为2300亿美元,其中580亿美元是遗漏的工资.
- 每个病例的平均替代成本为42,422美元,遗失的工资为10,677美元.
- 预计到2050年,预计的成本将近翻一番,达到每年4040亿美元.
结论:
- 在美国,非正式的痴呆症照顾是相当大的经济负担.
- 这些成本在各州有很大的差异,预计到2050年将大幅增加.
- 调查结果强调,需要为痴呆症护理人员更新政策和支持系统.
相关概念视频
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189
Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Documentation in Long-Term and Home Healthcare Setting
892
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
892
Aging
51
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
51


